#Fred Hutchinson

Safety tips for the evolving pandemic. Plus: Which groups—such as those with cancer or HIV—are at higher risk for COVID-19 complications?

The HVTN 302 trial is evaluating experimental vaccines that deliver stabilized HIV spike proteins.

An expanded HIV Vaccine Trials Network Faith Initiative aims to reach Black, Latino and Indigenous communities of faith. [VIDEO]

A survey of 6,500 HIV vaccine trial participants found that the good feeling involved with being altruistic was a major benefit.

Researchers hope to combine gene editing with a less toxic stem cell transplant. Findings may apply to cancer and other illnesses.

This strategy entails genetically modifying a person’s stem cells to give rise to T cells that target and destroy cells infected with HIV.

The NIH-funded network has launched its first clinical trial in response to the new pandemic.

Scientists and public health officials worldwide collaborate to understand COVID-19 and slow its spread.

International ‘dream team’ to use new technologies and prevention approaches to help those at highest risk.

Calling all U.S. cisgender gay and bi men and trans and gender nonconforming people at risk for the virus.

Experts discuss rapid changes in cancer treatment and in the management of infections that can accompany these therapies.

One hundred twenty volunteers to enroll in Seattle-area study of cancer-related gene mutations

Ten HIV-positive cancer patients to receive donated cord blood with rare resistance gene.

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials.